Benzylpenicillin: Clinical Trials

10 trials of Benzylpenicillin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 2 withdrawn, 1 not yet recruiting. 6 Phase 4, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 46Recruiting 2, Withdrawn 2, Not yet recruiting 1, Unknown 1
Phase 32Completed 1, Recruiting 1
Early Phase 11Terminated 1
Phase 11Completed 1

Follow Benzylpenicillin: new trials by email Literature Review of Benzylpenicillin trials Research Report on Benzylpenicillin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess
Benzylpenicillin, Isotonic NaCl (Placebo) - Acute Tonsillitis, Peritonsillar Abscess
Phase 4Not yet recruitingTejs Ehlers Klug1542026-10-012026-10-26
Continuous Antibiotic Infusion In Children
Benzylpenicillin - Infection
Phase 3RecruitingTampere University Hospital1502026-04-212026-05-08
Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia
Penicillin G_1200mg, cloxacillin - Staphylococcus Aureus Bacteraemia, Staphylococcal Bacteraemia
Phase 4RecruitingRegion Skane4202025-03-102026-04-30
Staphylococcus Aureus Network Adaptive Platform Trial
Cefazolin, Penicillin, Clindamycin - Staphylococcus Aureus Bacteremia
Phase 4RecruitingUniversity of Melbourne80002022-02-162026-05-06
Closed-loop Control of Penicillin Delivery
Microneedle array, Microneedle array and closed-loop control of penicillin delivery, Penicillin G_1200mg - Healthy Volunteers
Phase 1CompletedImperial College London62019-11-052024-07-10
Penicillin Against Flucloxacillin Treatment Evaluation
Benzylpenicillin, Flucloxacillin - Staphylococcus Aureus
Phase 4WithdrawnThe University of Queensland2019-07-012022-11-16
Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia
Continuous infusion of beta-lactam antibiotics ., Therapeutic drug monitoring of beta-lactam antibiotics. - Bacteremia
Phase 4WithdrawnSara Thønnings2017-10-012023-03-29
Patients Response to Early Switch To Oral:Osteomyelitis Study
oral antibiotics, intravenous antibiotics - Osteomyelitis
Early Phase 1TerminatedJulio Ramirez112014-03-062021-04-06
Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections
PCT-level, Antibiotic treatment based on PCT-level - Pneumonia, Acute Exacerbation of Chronic Obstructive Airways Disease
Phase 4UnknownHolbaek Sygehus552013-10-012014-08-15
Evaluation of Skin Testing Reagents for Penicillin Allergy
Penicillin skin test kit - History of IgE Dependent Reaction to a Penicillin Product
Phase 3CompletedAllerQuest LLC4812012-12-012017-01-04

Conditions studied

Bacteremia (2)  ·  Osteomyelitis (2)  ·  Staphylococcal Infections (2)  ·  Infections (1)  ·  Peritonsillar Abscess (1)  ·  Pneumonia (1)  ·  Sepsis (1)  ·  Toxemia (1)

Sponsors

AllerQuest LLC (1)  ·  Holbaek Sygehus (1)  ·  Imperial College London (1)  ·  Julio Ramirez (1)  ·  Region Skane (1)  ·  Sara Thønnings (1)  ·  Tampere University Hospital (1)  ·  Tejs Ehlers Klug (1)  ·  The University of Queensland (1)  ·  University of Melbourne (1)

Countries

United States (3)  ·  Australia (2)  ·  Denmark (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Singapore (1)  ·  South Africa (1)

Top investigators

Alison H Holmes, MD MPH MBBS (1)  ·  David Paterson (1)  ·  David Seligson, MD (1)  ·  Hans Ibsen, M.D., D.M.Sc (1)  ·  Julio Ramirez, MD (1)  ·  Malin Hagstrand Aldman, PhD, MD (1)  ·  N. Franklin Adkinson, Jr., MD (1)  ·  Prof Joshua Davies (1)  ·  Prof Steven Tong (1)  ·  Tejs E Klug, MD, DMSc (1)

Results publications

PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 39934879, PMID 41433510, PMID 42308484, PMID 42309115, PMID 4902833, PMID 8948280

NIH funding

2023 (1), 2025 (1)